D-Risk Investing Podcast

Can a 47-year-old tech giant have a mid-life crisis that sends its stock soaring over 30%? Oracle just did, revealing a jaw-dropping $455 billion in future AI and cloud contracts that have rewritten its entire narrative overnight. This move creates a battlefield for investors: on one side, traditional valuation models are flashing bright red warning signs, while on the other, Wall Street and bullish options traders are betting this is the start of a new AI-fueled dynasty. In this episode, we dive deep into the fundamental catalyst, market sentiment, and technical charts to determine if Oracle has truly transformed or if this massive rally is built on pure hype. Tune in for our final verdict and the key price levels that will decide the stock's fate in the coming days.

Eli Lilly (LLY) is a 150-year-old pharmaceutical giant that's suddenly acting like a Silicon Valley startup, with billion-dollar AI platforms and next-generation gene therapy deals—and the market is buying the story hook, line, and sinker. While bullish options traders are piling in and short-sellers are nowhere to be found, a deep dive into the numbers reveals a massive red flag: a valuation disconnect that suggests the stock is either a screaming buy or dangerously overhyped. With the price chart coiling like a spring for a major move, we dissect the fierce battle between an unstoppable narrative and the cautionary numbers. Tune in to find out if Eli Lilly is about to launch into the stratosphere or if its incredible story is about to collide with financial reality.

QuantumScape (QS) just ignited the market by putting its game-changing solid-state battery into a Ducati race bike, sparking an explosive technical breakout on a tidal wave of volume. But beneath this high-octane rally lies a fierce battleground. In one corner, you have a world-changing technology and a stampede of bullish options traders betting on a rocket launch. In the other, you have unprofitable financials, skeptical Wall Street analysts, and an army of short-sellers convinced the hype will burn out. In this episode, we dissect this high-stakes showdown to determine if this is the start of a legendary short squeeze or a hype-fueled trap. Tune in to uncover the one force that could tip the scales and the critical price levels that will decide the fight.

Citigroup (C) is the life of the party on Wall Street, smashing through a 52-week high on the back of stellar strategic moves and overwhelmingly bullish market sentiment. But what happens when the glowing headlines clash with the numbers? Digging beneath the surface, we uncover a stock that appears significantly overvalued, technical charts showing clear signs of exhaustion, and a troubling macroeconomic forecast looming in the background. In this episode, we dissect the fierce tug-of-war between flawless company execution and stretched fundamentals to answer the critical question: Is Citigroup poised for another leg up, or is this a bull trap forming at a dangerous peak? Tune in to find out where the smart money is heading and the key price levels that will decide the stock's next move.

Is Micron Technology ($MU) a rocket ship or a house of cards? On this episode of D-Risk, we dissect a stock where technical perfection clashes with fundamental red flags. While a powerful, money-in-the-bank uptrend is fueled by bullish analyst ratings and strong momentum, our valuation models reveal a shocking truth: the stock may be profoundly overvalued. With a shaky macro backdrop and a small but vocal group of bears betting against it, we ask: will this semiconductor giant continue its flawless climb, or is it heading for a sharp, painful correction? Tune in to learn the key levels to watch and which force is likely to win the battle for Micron's future.

Is Western Digital ($WDC) a rocket ship or a house of cards? On this episode of D-Risk, we connect with a data storage giant at a critical crossroads. While analysts are overwhelmingly bullish and a powerful technical trend is in play, we uncover a fascinating conflict: the stock is flashing "overbought" signals just as the broader economy shows signs of a recession. With a massive short interest betting against the stock, we dive into the data to reveal the key number that will decide WDC's fate. Will the momentum continue, or is this high-flying stock due for a major system error? Tune in to find out if it's time to back up your gains or format for a fresh start.

Getting an invite to the S&P 500 is a huge deal—but for Robinhood ($HOOD), is it a golden ticket or a trap? On this episode of D-Risk, we dive into a classic Wall Street dilemma: a game-changing catalyst versus a stock price that may have already run too far. While S&P inclusion is a guaranteed demand event, our analysis uncovers a shaky fundamental valuation, weakening technicals, and a murky macroeconomic backdrop. Will the headline triumph over the trendline, or is this the perfect opportunity for bears to strike? Tune in as we dissect the data and give you the strategic outlook on a stock caught between explosive news and a brewing storm.

Is DocuSign (DOCU) more than just a pandemic relic? Following a blockbuster earnings report and a strategic shift into AI, the company is making a comeback. We’re diving into the DocuSign stock analysis to see if its AI-powered pivot can silence the skeptics and justify a move higher. Discover why the fundamental story is bullish, even as analysts remain on the sidelines, and get a data-driven breakdown of the technical picture. Whether you're a believer in AI stocks or a savvy investor looking for an undervalued play, this episode of D-Risk gives you the full story on what's driving DocuSign's new chapter.

Lululemon just had a major earnings face-plant, sending its stock plunging. Is this a once-in-a-lifetime chance to buy a premium brand at a discount, or a warning sign of deeper problems? In this episode of D-Risk, we dive into the Lululemon stock analysis. We break down the brutal earnings report, a surprising valuation conflict, and what the technical charts are screaming. If you're an investor trying to navigate the volatile world of retail stocks or looking for insights into Lululemon's stock price, this episode gives you the data-driven truth on whether this company is a broken brand or a bounce-back waiting to happen.

Broadcom (AVGO) just announced a $10 billion AI chip order. Is this the ultimate cheat code for the global economy, or is the stock's sky-high price a trap? Dive deep into the Broadcom stock analysis with D-Risk, a podcast that cuts through the noise. We break down the macro trends, the company's blockbuster earnings, and what the technical charts are telling us. Whether you’re an investor interested in semiconductor stocks or looking for an edge in AI investing, this episode is your no-nonsense guide to understanding if Broadcom's explosive growth is too good to be true. Tune in and get the data-driven insights you need to make smarter, less risky investment decisions.